BAK additive influence on results
Rupali D Shah, Thomas I Lemon, Ashley Yarrow-JenkinsInstitute of Medical Education, Cardiff University, Cardiff, Wales, UKThis letter is in regards to Fukuda et al.1 We thank the authors for their informative contribution. The use of rabbit specimens was relevant to this study as previously alluded...
Guardado en:
Autores principales: | Shah RD, Lemon TI, Yarrow-Jenkins A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b372d79beec4ddbaa2b67d65030f287 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relationship between interblink interval and dopamine
por: Lemon TI, et al.
Publicado: (2013) -
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Gregory Katz, et al.
Publicado: (2010) -
First experience with BAK-free travoprost 0.004% in topical glaucoma medication
por: Gado AS, et al.
Publicado: (2011) -
Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
por: Inoue K, et al.
Publicado: (2012) -
Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy
por: J Charles Henry, et al.
Publicado: (2008)